Free Trial

Intellia Therapeutics (NTLA) Insider Trading & Ownership

Intellia Therapeutics logo
$13.09 -1.19 (-8.33%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$13.08 0.00 (-0.04%)
As of 07:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.00M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$675.49K
Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTLA Insider Buying and Selling by Quarter

Intellia Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/5/2026Sell8,508$9.21$78,358.68  
1/5/2026Sell10,397$9.21$95,756.37  
1/5/2026Sell34,146$9.21$314,484.66  
10/1/2025Sell31$17.38$538.78  
10/1/2025Sell1,871$17.38$32,517.98  
8/20/2025Buy100,000$10.03$1,003,000.00  
7/23/2025Sell7,462$14.02$104,617.24  
7/2/2025Sell2,503$9.95$24,904.85  
7/1/2025Sell1,022$9.82$10,036.04  
7/1/2025Sell1,547$9.23$14,278.81  
(Data available from 1/1/2013 forward)

NTLA Insider Trading Activity - Frequently Asked Questions

3.10% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings.

The following insider purchased NTLA shares in the last 24 months: William J Chase ($1,003,000.00).

Insiders have purchased a total of 100,000 NTLA shares in the last 24 months for a total of $1,003,000.00 bought.

The following insiders have sold NTLA shares in the last 24 months: Birgit C Schultes ($78,897.46), Edward J Dulac III ($104,617.24), Eliana Clark ($26,011.37), James Basta ($95,756.37), Jesse Goodman ($14,278.81), John M Leonard ($640,993.92), Michael P Dube ($112,381.91), and Muna Bhanji ($4,894.55).

Insiders have sold a total of 99,169 Intellia Therapeutics shares in the last 24 months for a total of $1,077,831.63 sold.



This page (NASDAQ:NTLA) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners